ArticleJapanese journal of clinical oncologyPublished
Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Japanese journal of clinical oncology
- Published
- Topic
- Clinical care
- Subject terms
- Japan; risk factors; Disease Progression; Smoldering Multiple Myeloma; Daratumumab
- PubMed ID
- 42747040
- Added to directory
- Source checked